Altri SGPS SA (ALTR)
Euronext Lisbon · Portugal · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 4.275 |
|---|---|
| 52-week range | 4.205 – 5.390 |
| Return, 1 month / 3 months | −9.8% / −8.3% |
| Return, 1 year / 3 years | −10.6% / +15.0% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 18.0% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 1.27M EUR |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Altri SGPS is a Portuguese industrial group based in Porto that produces bleached eucalyptus kraft pulp at its mills in Portugal. It supplies pulp to paper and tissue makers and also generates electricity, largely from biomass, at its industrial sites. The company manages forest resources to feed its mills and sells surplus power. Its customers are mainly industrial paper producers in Europe and beyond, and its operations centre on the Iberian peninsula.
Altri SGPS SA trades under the code ALTR on the Euronext Lisbon in Portugal, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Altri SGPS SA (ALTR) trades on the Euronext Lisbon in Portugal. It last closed at EUR 4.275 on 23 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 17 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.6% and over the last three months it fell 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.8% | ||
| From 52-week high | -18.4% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.3% | ||
| 6-month return | -8.5% | ||
| 12-month return, skipping the last month | -0.8% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.27M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −9.8% |
| 3 months | −8.3% |
| 6 months | −8.5% |
| 1 year | −10.6% |
| 3 years | +15.0% |
| 5 years | +59.1% |
Signals
| 50-day / 200-day average | 4.594 / 4.636 |
|---|---|
| Golden / death cross (60 days) | Death, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.079 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 0.2500 |
| 15 May 2025 | EUR 0.3000 |
| 21 May 2024 | EUR 0.2500 |
| 16 May 2023 | EUR 0.2500 |
| 12 May 2023 | EUR 0.1061 |
| 17 May 2022 | EUR 0.2036 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.